Predicting the 2030 Landscape: Strategic Projections and Long-Term Trends in the Small Molecule Drug Discovery Market Forecast
The strategic horizon for drug development is shifting toward more sustainable and cost-effective models. As patents for major blockbuster drugs expire, the race to fill the generic and branded pipeline is intensifying. Small molecule drug discovery is benefiting from a "fail fast, fail early" mentality, where advanced predictive toxicology models are used to weed out unsuccessful candidates...
0 Commenti 0 condivisioni 220 Views 0 Anteprima